ArticleCells2021

A Preclinical Investigation of GBM-N019 as a Potential Inhibitor of Glioblastoma via Exosomal mTOR/CDK6/STAT3 Signaling.

Alexander T H Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.